ITNA960038A0 - - Google Patents

Info

Publication number
ITNA960038A0
ITNA960038A0 ITNA960038A ITNA960038A ITNA960038A0 IT NA960038 A0 ITNA960038 A0 IT NA960038A0 IT NA960038 A ITNA960038 A IT NA960038A IT NA960038 A ITNA960038 A IT NA960038A IT NA960038 A0 ITNA960038 A0 IT NA960038A0
Authority
IT
Italy
Application number
ITNA960038A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IT96NA000038A priority Critical patent/IT1294964B1/en
Publication of ITNA960038A0 publication Critical patent/ITNA960038A0/it
Priority to AU35575/97A priority patent/AU3557597A/en
Priority to PCT/IT1997/000162 priority patent/WO1998002528A1/en
Publication of ITNA960038A1 publication Critical patent/ITNA960038A1/en
Application granted granted Critical
Publication of IT1294964B1 publication Critical patent/IT1294964B1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/14—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
IT96NA000038A 1996-07-12 1996-07-12 INSULATION AND CULTURE OF FETAL CELLS FROM THE MATERNAL PERIPHERAL BLOOD IT1294964B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT96NA000038A IT1294964B1 (en) 1996-07-12 1996-07-12 INSULATION AND CULTURE OF FETAL CELLS FROM THE MATERNAL PERIPHERAL BLOOD
AU35575/97A AU3557597A (en) 1996-07-12 1997-07-09 The isolation and culture of fetal cells from peripheral maternal blood
PCT/IT1997/000162 WO1998002528A1 (en) 1996-07-12 1997-07-09 The isolation and culture of fetal cells from peripheral maternal blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96NA000038A IT1294964B1 (en) 1996-07-12 1996-07-12 INSULATION AND CULTURE OF FETAL CELLS FROM THE MATERNAL PERIPHERAL BLOOD

Publications (3)

Publication Number Publication Date
ITNA960038A0 true ITNA960038A0 (en) 1996-07-12
ITNA960038A1 ITNA960038A1 (en) 1998-01-12
IT1294964B1 IT1294964B1 (en) 1999-04-23

Family

ID=11387897

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96NA000038A IT1294964B1 (en) 1996-07-12 1996-07-12 INSULATION AND CULTURE OF FETAL CELLS FROM THE MATERNAL PERIPHERAL BLOOD

Country Status (3)

Country Link
AU (1) AU3557597A (en)
IT (1) IT1294964B1 (en)
WO (1) WO1998002528A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004029221A2 (en) 2002-09-27 2004-04-08 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
DK1816461T3 (en) 2002-10-16 2020-04-14 Streck Laboratories Inc Method and apparatus for collecting and securing cells for analysis
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
GB0509500D0 (en) * 2005-05-10 2005-06-15 Revealcyte Method of fetal cell enrichment
EP1915618A4 (en) 2005-06-02 2009-09-30 Fluidigm Corp Analysis using microfluidic partitioning devices
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US20080070792A1 (en) 2006-06-14 2008-03-20 Roland Stoughton Use of highly parallel snp genotyping for fetal diagnosis
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
AU2007311126A1 (en) * 2006-10-16 2008-04-24 Celula Inc. Methods and compositions for differential expansion of fetal cells in maternal blood and their use
LT2334812T (en) 2008-09-20 2017-04-25 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US11634747B2 (en) 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
EP2398912B1 (en) 2009-02-18 2017-09-13 Streck Inc. Preservation of cell-free nucleic acids
EP3284346B1 (en) † 2010-10-15 2021-07-07 Bayer CropScience Aktiengesellschaft Use of als inhibitor herbicides for control of unwanted vegetation in als inhibitor herbicide tolerant beta vulgaris plants
EP2704740B1 (en) 2011-05-04 2016-10-05 Streck, Inc. Inactivated swine flu virus and methods of preparing it
CA2874343C (en) 2012-05-21 2021-11-09 Fluidigm Corporation Single-particle analysis of particle populations
CA2876692C (en) 2012-06-22 2022-05-24 Quantrx Biomedical Corporation Method for obtaining fetal cells and fetal cellular components
ES2938048T3 (en) 2013-07-24 2023-04-04 Streck Llc Compositions and methods for stabilizing circulating tumor cells
US10962622B2 (en) 2013-12-23 2021-03-30 Rosemount Inc. Analog process variable transmitter with electronic calibration
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
WO2018022991A1 (en) 2016-07-29 2018-02-01 Streck, Inc. Suspension composition for hematology analysis control

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05501612A (en) * 1989-11-13 1993-03-25 チルドレンズ・メデイカル・センター・コーポレーシヨン Non-invasive methods for fetal DNA isolation and detection
JPH05507404A (en) * 1990-04-23 1993-10-28 セルプロ　インコーポレイティド Method for enrichment of fetal cells from maternal blood
US5714325A (en) * 1993-09-24 1998-02-03 New England Medical Center Hospitals Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
JPH09510875A (en) * 1994-03-29 1997-11-04 ジェンザイム・コーポレイション Culture and isolation of fetal cells from maternal peripheral blood
JPH10507632A (en) * 1994-09-20 1998-07-28 ミルテニー バイオテック，インコーポレイティド Concentration of fetal blood from the mother

Also Published As

Publication number Publication date
AU3557597A (en) 1998-02-09
IT1294964B1 (en) 1999-04-23
WO1998002528A1 (en) 1998-01-22
ITNA960038A1 (en) 1998-01-12

Similar Documents

Publication Publication Date Title
BRPI9713914B8 (en)
IN183687B (en)
ITNA960038A0 (en)
IN192470B (en)
ITMI960229A0 (en)
IN186517B (en)
ITMI960658V0 (en)
IN188438B (en)
IN191467B (en)
IN192034B (en)
IN186079B (en)
IN184641B (en)
ITMI960206A0 (en)
ECSDI960301S (en)
ITMI960308A0 (en)
CN3044346S (en)
EP0959884A4 (en)
CN3042289S (en)
CN3043305S (en)
CN3041374S (en)
CN3044168S (en)
CN3047747S (en)
CN3044347S (en)
CN3045911S (en)
CN3044348S (en)

Legal Events

Date Code Title Description
0001 Granted